Major players in the implantable drug delivery devices market are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc, Merck, Genetech Inc., and Psivida.
The global implantable drug delivery devices market is expected to grow from $18.821 billion in 2020 to $20.137 billion in 2021 at a compound annual growth rate (CAGR) of 7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $29.846 billion in 2025 at a CAGR of 10%.
The implantable drug delivery devices market consists of sales of implantable drug delivery devices and related services by companies that manufacture them. Implantable drug delivery devices are drug delivery systems implanted by surgery to allow site-specific drug administration at the tissue or organ where the drug is most needed.
Companies and researchers are focusing on developing 3D implantable drug delivery devices. 3D printed titanium transcutaneous ports are implanted behind the patient’s ear, allowing healthcare professionals to access the catheters. For instance, in February 2020, Renishaw and Herantis Pharma announced the award-winning device, which received positive results in phase 2 trials, that consists of up to four catheters implanted in the relevant brain areas. Researchers at King Abdullah University of Science and Technology have introduced a miniaturized drug delivery system suitable for in-vivo biomedical applications. The system consists of an electrolytic pump, which operates a micro bellows membrane as an actuator for delivery through microneedles. A two-photon 3D printing technique was used to make a reservoir equipped with a microneedle.
The implantable drug delivery device market covered in this report is segmented by product into contraceptive implants; spinal implants; brachytherapy seeds; drug-eluting stents; bio-absorbable stents; intraocular stents; infusion pumps; others. It is also segmented by technology into diffusion; osmotic; magnetic; others, and by application into contraception; ophthalmology; cardiovascular; diabetes; oncology; autoimmune diseases; others.
The rising number of product recalls and lawsuits associated with the implantable drug delivery devices is expected to hinder the market.In the past few years, there had been an increase in product recalls and lawsuits connected with these devices.
For instance, in December 2019, around 7,000 Medtronic SynchroMed II implantable drug infusion pumps were recalled due to the presence of foreign bodies in them.Nexplanon, a small rod contraceptive implant inserted into the skin of the upper arm to prevent pregnancy for up to three years, is facing a lawsuit, and lawyers and attorneys at National Injury Help have been investigating all such cases against those injured by Nexplanon.
Therefore, the rising number of product recalls and lawsuits concerning implantable drug delivery devices is expected to hinder the growth of the market.
In November 2019, Dare Bioscience, a USA-based biopharmaceutical company with a special focus on women’s health, has acquired Microchips Biotech for an amount of $102 million.Through this acquisition, Microchips has become the wholly subsidiary of Dare Bioscience.
Microchips Biotech is a USA-based company developing innovative drug implants.
The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases and other chronic diseases is expected to drive the implantable drug delivery devices market.According to the International Diabetes Federation (IDF), the global prevalence of diabetic retinopathy was around 27% between 2015 and 2019.
Implantable drug delivery devices are used for site-specific drug administration where the drug is most needed, such as Gliadel® wafer as an implant used in the treatment of brain tumors, Lupron® depot for the treatment of prostate cancer. Hence, due to the site-specific drug administration nature of implantable drug devices, which help in the treatment of target diseases, is driving the implantable drug delivery devices market.
Our reports have been used by over 10K customers, including:
This report aims to provide a comprehensive study of the global market for transdermal drug delivery technologies/systems. It provides a detailed description of the different types of transdermal drug delivery systems (passive and active) and the current and historical market revenues.
693 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Jul 2021
Drug Delivery Systems (DDS) are the advanced formulations or technologies that modulate the release profile of therapeutic or prophylactic agents, their absorption, distribution and elimination characteristics to achieve the desired therapeutic effect and enhance the safety profile, patient convenience and compliance to medications...
Report Scope This report analyzes the market trends of microneedles with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through the forecast period of 2021 to 2026). Regulatory scenarios, drivers, restraints and opportunities will be covered, as well as market shares for leading...
The India Nano Gold Market by Type (Water Soluble, Oil Soluble, and Others), Diameter Size (Less than 40 nm, 40 to 100 nm, 101 to 400 nm, and Others), Application (Imaging, Targeted Drug Delivery, Sensors, In Vitro Diagnostics, Probes, Catalysis, and Others), and End User (Electronics, Healthcare, Chemicals, and Others): Opportunity...
The global microspheres market reached a value of US$ 4.6 Billion in 2020. Microspheres refer to solid sphere-shaped particles available in sizes ranging from 1 to 1000 µm. They are usually made using glass, ceramic, fly ash, metal and polymers and have controlled opacity, particle size distribution, gravity and electrostatic charge. In the...
248 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Drug Delivery System has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
175 pages •
By The Business Research Company
• May 2021
Major players in the liposomal drug delivery devices market are, Fudan-Zhangjiang, Pacira, Johnson and Johnson, Gilead Sciences, Novartis, Luye Pharma, CSPC, Ipsen (Onivyde), and Teva Pharmaceutical. The global liposomal drug delivery devices market is expected to grow from $3.304 billion in 2020 to $3.644 billion in 2021 at a compound...
‘Elastomeric Pumps- Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of elastomeric pumps and the historical and forecasted elastomeric pumps market trends in the US, EU5 (Germany, France, Spain, Italy, and United Kingdom) and Japan.
The elastomeric pumps market report provides...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the diuretic drugs market are Merck & Co., Meda Manufacturing GmbH, Pfizer Inc., Glaxosmithkline and Roche. The global diuretics market is expected to grow from $0.82 billion in 2020 to $0.91 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies rearranging their operations...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.